Argan Inc

AGX is in a Stage 4 decline with price trading below declining 9, 21, and 50 EMAs, confirmed by an active Lower Highs & Lower Lows pattern. Medium- and short-term biases are bearish, and execution should be deferred until rallies back toward the EMA cluster offer better sell-side entry. Despite extreme oversold readings and support near the 200 DMA, no stable base or clear mean-reversion signal has formed.

• ↑Q1 2027 revenue $291M (+50% YoY) driven by power segment boom
• ↑Net income $46M ($3.24/share), gross margin rose to 21% from 19%
• ↓Shares trade at high valuation with low earnings yield and poor book-to-price